ConductScience.org, home

Comparison · NCT04588207-7f8bc805

Urea vs No Urea: Number and Proportion of Participants Enrolled in the Study With Adverse Events Related to the Use of Urea

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Urea vs No Urea: Number and Proportion of Participants Enrolled in the Study With Adverse Events Related to the Use of Urea. Trial comparisons, record NCT04588207-7f8bc805. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04588207-7f8bc805

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.50.09450.905wilson
Risk in group 2000.658wilson
Risk difference, group 1 minus group 20.5-0.2730.905newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treat, for one more participant with the outcome on Urea than on No Urea2from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1UreaParticipants assigned to this group will receive oral urea for 42 days12OG000
Group 2No UreaParticipants assigned to this group will be off urea for 42 days02OG001

Outcome

Type
PRIMARY
Title
Number and Proportion of Participants Enrolled in the Study With Adverse Events Related to the Use of Urea
Description
Number and proportion of participants enrolled in the study with adverse events related to the use of urea from baseline to day 42. To be assessed by medication side effect questionnaire.
Time frame
Baseline to day 42 while taking urea
Population
This measure is only relevant when on urea

Source ClinicalTrials.gov

Trial

Title
Urea for Chronic Hyponatremia
NCT number
NCT04588207
Phases
PHASE2
Conditions
Hyponatremia, Inappropriate ADH Syndrome
Interventions
Urea
Lead sponsor
Helbert Rondon Berrios, MD, MS
Results first posted
2024-05-20

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04588207-7f8bc805